Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Residual Disease Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Tumor-informed Assays
1.2.3 Tumor-agnostic Assays
1.3 Market by Application
1.3.1 Global Molecular Residual Disease Detection Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Prognosis
1.3.3 Adjuvant Treatment Decision-Making
1.3.4 Surveillance for Postoperative Recurrence
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Residual Disease Detection Market Perspective (2018-2033)
2.2 Molecular Residual Disease Detection Growth Trends by Region
2.2.1 Global Molecular Residual Disease Detection Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Residual Disease Detection Historic Market Size by Region (2018-2023)
2.2.3 Molecular Residual Disease Detection Forecasted Market Size by Region (2024-2033)
2.3 Molecular Residual Disease Detection Market Dynamics
2.3.1 Molecular Residual Disease Detection Industry Trends
2.3.2 Molecular Residual Disease Detection Market Drivers
2.3.3 Molecular Residual Disease Detection Market Challenges
2.3.4 Molecular Residual Disease Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Residual Disease Detection Players by Revenue
3.1.1 Global Top Molecular Residual Disease Detection Players by Revenue (2018-2023)
3.1.2 Global Molecular Residual Disease Detection Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Residual Disease Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Residual Disease Detection Revenue
3.4 Global Molecular Residual Disease Detection Market Concentration Ratio
3.4.1 Global Molecular Residual Disease Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Residual Disease Detection Revenue in 2022
3.5 Molecular Residual Disease Detection Key Players Head office and Area Served
3.6 Key Players Molecular Residual Disease Detection Product Solution and Service
3.7 Date of Enter into Molecular Residual Disease Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Residual Disease Detection Breakdown Data by Type
4.1 Global Molecular Residual Disease Detection Historic Market Size by Type (2018-2023)
4.2 Global Molecular Residual Disease Detection Forecasted Market Size by Type (2024-2033)
5 Molecular Residual Disease Detection Breakdown Data by Application
5.1 Global Molecular Residual Disease Detection Historic Market Size by Application (2018-2023)
5.2 Global Molecular Residual Disease Detection Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Residual Disease Detection Market Size (2018-2033)
6.2 North America Molecular Residual Disease Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Residual Disease Detection Market Size by Country (2018-2023)
6.4 North America Molecular Residual Disease Detection Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Residual Disease Detection Market Size (2018-2033)
7.2 Europe Molecular Residual Disease Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Residual Disease Detection Market Size by Country (2018-2023)
7.4 Europe Molecular Residual Disease Detection Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Residual Disease Detection Market Size (2018-2033)
8.2 Asia-Pacific Molecular Residual Disease Detection Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Residual Disease Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Residual Disease Detection Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Residual Disease Detection Market Size (2018-2033)
9.2 Latin America Molecular Residual Disease Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Residual Disease Detection Market Size by Country (2018-2023)
9.4 Latin America Molecular Residual Disease Detection Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Residual Disease Detection Market Size (2018-2033)
10.2 Middle East & Africa Molecular Residual Disease Detection Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Residual Disease Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Residual Disease Detection Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptive
11.1.1 Adaptive Company Detail
11.1.2 Adaptive Business Overview
11.1.3 Adaptive Molecular Residual Disease Detection Introduction
11.1.4 Adaptive Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.1.5 Adaptive Recent Development
11.2 Guardant Health
11.2.1 Guardant Health Company Detail
11.2.2 Guardant Health Business Overview
11.2.3 Guardant Health Molecular Residual Disease Detection Introduction
11.2.4 Guardant Health Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.2.5 Guardant Health Recent Development
11.3 Invitae
11.3.1 Invitae Company Detail
11.3.2 Invitae Business Overview
11.3.3 Invitae Molecular Residual Disease Detection Introduction
11.3.4 Invitae Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.3.5 Invitae Recent Development
11.4 Cergentis B.V
11.4.1 Cergentis B.V Company Detail
11.4.2 Cergentis B.V Business Overview
11.4.3 Cergentis B.V Molecular Residual Disease Detection Introduction
11.4.4 Cergentis B.V Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.4.5 Cergentis B.V Recent Development
11.5 LexentBio
11.5.1 LexentBio Company Detail
11.5.2 LexentBio Business Overview
11.5.3 LexentBio Molecular Residual Disease Detection Introduction
11.5.4 LexentBio Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.5.5 LexentBio Recent Development
11.6 Natera
11.6.1 Natera Company Detail
11.6.2 Natera Business Overview
11.6.3 Natera Molecular Residual Disease Detection Introduction
11.6.4 Natera Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.6.5 Natera Recent Development
11.7 BGI
11.7.1 BGI Company Detail
11.7.2 BGI Business Overview
11.7.3 BGI Molecular Residual Disease Detection Introduction
11.7.4 BGI Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.7.5 BGI Recent Development
11.8 Zhiben Medical
11.8.1 Zhiben Medical Company Detail
11.8.2 Zhiben Medical Business Overview
11.8.3 Zhiben Medical Molecular Residual Disease Detection Introduction
11.8.4 Zhiben Medical Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.8.5 Zhiben Medical Recent Development
11.9 Burning Rock Medicine
11.9.1 Burning Rock Medicine Company Detail
11.9.2 Burning Rock Medicine Business Overview
11.9.3 Burning Rock Medicine Molecular Residual Disease Detection Introduction
11.9.4 Burning Rock Medicine Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.9.5 Burning Rock Medicine Recent Development
11.10 Huidu Medical
11.10.1 Huidu Medical Company Detail
11.10.2 Huidu Medical Business Overview
11.10.3 Huidu Medical Molecular Residual Disease Detection Introduction
11.10.4 Huidu Medical Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.10.5 Huidu Medical Recent Development
11.11 Zhenhe Technology
11.11.1 Zhenhe Technology Company Detail
11.11.2 Zhenhe Technology Business Overview
11.11.3 Zhenhe Technology Molecular Residual Disease Detection Introduction
11.11.4 Zhenhe Technology Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.11.5 Zhenhe Technology Recent Development
11.12 ExactSciences
11.12.1 ExactSciences Company Detail
11.12.2 ExactSciences Business Overview
11.12.3 ExactSciences Molecular Residual Disease Detection Introduction
11.12.4 ExactSciences Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.12.5 ExactSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Residual Disease Detection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Tumor-informed Assays
Table 3. Key Players of Tumor-agnostic Assays
Table 4. Global Molecular Residual Disease Detection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Molecular Residual Disease Detection Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Molecular Residual Disease Detection Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Molecular Residual Disease Detection Market Share by Region (2018-2023)
Table 8. Global Molecular Residual Disease Detection Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Molecular Residual Disease Detection Market Share by Region (2024-2033)
Table 10. Molecular Residual Disease Detection Market Trends
Table 11. Molecular Residual Disease Detection Market Drivers
Table 12. Molecular Residual Disease Detection Market Challenges
Table 13. Molecular Residual Disease Detection Market Restraints
Table 14. Global Molecular Residual Disease Detection Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Molecular Residual Disease Detection Market Share by Players (2018-2023)
Table 16. Global Top Molecular Residual Disease Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Residual Disease Detection as of 2022)
Table 17. Ranking of Global Top Molecular Residual Disease Detection Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Molecular Residual Disease Detection Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Molecular Residual Disease Detection Product Solution and Service
Table 21. Date of Enter into Molecular Residual Disease Detection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Molecular Residual Disease Detection Revenue Market Share by Type (2018-2023)
Table 25. Global Molecular Residual Disease Detection Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Molecular Residual Disease Detection Revenue Market Share by Type (2024-2033)
Table 27. Global Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Molecular Residual Disease Detection Revenue Market Share by Application (2018-2023)
Table 29. Global Molecular Residual Disease Detection Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Molecular Residual Disease Detection Revenue Market Share by Application (2024-2033)
Table 31. North America Molecular Residual Disease Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Molecular Residual Disease Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Molecular Residual Disease Detection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Molecular Residual Disease Detection Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Molecular Residual Disease Detection Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Molecular Residual Disease Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Molecular Residual Disease Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 46. Adaptive Company Detail
Table 47. Adaptive Business Overview
Table 48. Adaptive Molecular Residual Disease Detection Product
Table 49. Adaptive Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 50. Adaptive Recent Development
Table 51. Guardant Health Company Detail
Table 52. Guardant Health Business Overview
Table 53. Guardant Health Molecular Residual Disease Detection Product
Table 54. Guardant Health Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 55. Guardant Health Recent Development
Table 56. Invitae Company Detail
Table 57. Invitae Business Overview
Table 58. Invitae Molecular Residual Disease Detection Product
Table 59. Invitae Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 60. Invitae Recent Development
Table 61. Cergentis B.V Company Detail
Table 62. Cergentis B.V Business Overview
Table 63. Cergentis B.V Molecular Residual Disease Detection Product
Table 64. Cergentis B.V Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 65. Cergentis B.V Recent Development
Table 66. LexentBio Company Detail
Table 67. LexentBio Business Overview
Table 68. LexentBio Molecular Residual Disease Detection Product
Table 69. LexentBio Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 70. LexentBio Recent Development
Table 71. Natera Company Detail
Table 72. Natera Business Overview
Table 73. Natera Molecular Residual Disease Detection Product
Table 74. Natera Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 75. Natera Recent Development
Table 76. BGI Company Detail
Table 77. BGI Business Overview
Table 78. BGI Molecular Residual Disease Detection Product
Table 79. BGI Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 80. BGI Recent Development
Table 81. Zhiben Medical Company Detail
Table 82. Zhiben Medical Business Overview
Table 83. Zhiben Medical Molecular Residual Disease Detection Product
Table 84. Zhiben Medical Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 85. Zhiben Medical Recent Development
Table 86. Burning Rock Medicine Company Detail
Table 87. Burning Rock Medicine Business Overview
Table 88. Burning Rock Medicine Molecular Residual Disease Detection Product
Table 89. Burning Rock Medicine Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 90. Burning Rock Medicine Recent Development
Table 91. Huidu Medical Company Detail
Table 92. Huidu Medical Business Overview
Table 93. Huidu Medical Molecular Residual Disease Detection Product
Table 94. Huidu Medical Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 95. Huidu Medical Recent Development
Table 96. Zhenhe Technology Company Detail
Table 97. Zhenhe Technology Business Overview
Table 98. Zhenhe Technology Molecular Residual Disease Detection Product
Table 99. Zhenhe Technology Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 100. Zhenhe Technology Recent Development
Table 101. ExactSciences Company Detail
Table 102. ExactSciences Business Overview
Table 103. ExactSciences Molecular Residual Disease Detection Product
Table 104. ExactSciences Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 105. ExactSciences Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Residual Disease Detection Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Molecular Residual Disease Detection Market Share by Type: 2022 VS 2033
Figure 3. Tumor-informed Assays Features
Figure 4. Tumor-agnostic Assays Features
Figure 5. Global Molecular Residual Disease Detection Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Molecular Residual Disease Detection Market Share by Application: 2022 VS 2033
Figure 7. Prognosis Case Studies
Figure 8. Adjuvant Treatment Decision-Making Case Studies
Figure 9. Surveillance for Postoperative Recurrence Case Studies
Figure 10. Other Case Studies
Figure 11. Molecular Residual Disease Detection Report Years Considered
Figure 12. Global Molecular Residual Disease Detection Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Molecular Residual Disease Detection Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Molecular Residual Disease Detection Market Share by Region: 2022 VS 2033
Figure 15. Global Molecular Residual Disease Detection Market Share by Players in 2022
Figure 16. Global Top Molecular Residual Disease Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Residual Disease Detection as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Molecular Residual Disease Detection Revenue in 2022
Figure 18. North America Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 20. United States Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 24. Germany Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Molecular Residual Disease Detection Market Share by Region (2018-2033)
Figure 32. China Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 40. Mexico Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 44. Turkey Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Adaptive Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 47. Guardant Health Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 48. Invitae Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 49. Cergentis B.V Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 50. LexentBio Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 51. Natera Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 52. BGI Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 53. Zhiben Medical Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 54. Burning Rock Medicine Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 55. Huidu Medical Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 56. Zhenhe Technology Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 57. ExactSciences Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed